- JPMorgan analyst Philip Cusick upgraded Gogo Inc (NASDAQ:GOGO) to Neutral from Underweight with a price target of $16, up from $11, implying a 6.81% upside.
- The company recently announced improved long-term financial targets based on record equipment sales, which management has now flowed through into overall long-term expectations, Cusick notes.
- The analyst likes the improving outlook at Gogo and expects the elevated level of activity will continue post-pandemic.
- He upgrades the stock to Neutral post the recent volatility.
- Price Action: GOGO shares traded higher by 3.40% at $15.49 in the premarket session on the last check Thursday.
Chemomab Therapeutics Announces Data Supporting Role Of Chemomab’s Novel Therapeutic Target CCL24 In Systemic Sclerosis Presented At EULAR 2022
Chemomab Therapeutics, Ltd. (NASDAQ:CMMB) (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory diseases with high unmet
